false
0001534154
0001534154
2026-08-26
2026-08-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): August
26, 2026

authID
Inc.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-40747 |
|
46-2069547 |
(State
or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification Number) |
1580
N. Logan St, Suite
660, Unit
51767, Denver,
Colorado
80203
(Address
of principal executive offices) (zip code)
516-274-8700
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.0001 per share |
|
AUID |
|
The
Nasdaq
Stock Market, LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
Resignation
of Chief Executive Officer/Appointment of Chairman of the Board
On
August 26, 2026, Rhoniel A. Daguro notified the Board of Directors of the Company (the “Board”) of his resignation as Chief
Executive Officer of the Company, effective September 4, 2026. Mr. Daguro will continue to serve as a member of the Board. On August
28, 2026, the Board accepted Mr. Daguro’s resignation and acknowledged that such resignation constitutes a resignation for “Good
Reason” as that term is defined in the Executive Retention Agreement dated as of March 23, 2023 between the Company and Mr. Daguro
(the “Retention Agreement”). Mr. Daguro’s resignation as Chief Executive Officer was not the result of any disagreement
with the Company on any matter relating to the Company’s operations, policies or practices. On August 28, 2026, the Board appointed
Mr. Daguro to serve as Chairman of the Board, effective immediately, for the remainder of his current elected term as a director, subject
to his earlier resignation or removal in accordance with the Company’s Amended and Restated By-Laws.
Appointment
of Interim Chief Executive Officer
On
August 28, 2026, the Board appointed Thomas R. Szoke, the Company’s Chief Technology Officer, as Interim Chief Executive Officer
of the Company, effective September 4, 2026. Mr. Szoke will continue to serve as the Company’s Chief Technology Officer.
Mr.
Szoke, age 62, is a co-founder of the Company and has over 35 years of executive management, solutions engineering and operations management
experience in the government security, identity access management and SaaS solutions industries. Mr. Szoke rejoined the Company on March
9, 2023 and, in April 2023, was appointed Chief Technology Officer of the Company. He served as a director of the Company from March
2023 until June 2025. Mr. Szoke previously served as a director and as the Company’s Chief Solutions Architect, and held several
other executive positions with the Company from its inception in 2013 through 2021. From 2021 to 2023, Mr. Szoke was an independent consultant
to the Company and to others. Mr. Szoke has been issued several U.S. and international patents focused on identity solutions and pioneered
the concept and development of several of the Company’s product lines, including its Multi-Factor Out-of-Band Identity and Transaction
Authentication Platform.
There
are no family relationships between Mr. Szoke and any director or executive officer of the Company, and there are no arrangements or
understandings between Mr. Szoke and any other person pursuant to which he was appointed as Interim Chief Executive Officer. There are
no transactions between the Company and Mr. Szoke that are required to be disclosed pursuant to Item 404(a) of Regulation S-K, other
than as described in this Current Report on Form 8-K.
Compensatory
Arrangements of Certain Officers
On
August 28, 2026, in connection with the foregoing, the Company entered into a letter agreement with each of Mr. Szoke (the “Szoke
Letter”) and Mr. Daguro (the “Daguro Letter” and, together with the Szoke Letter, the “Letter Agreements”).
Each of the Letter Agreements defines a “Corporate Transaction” as the closing of a material transaction with a minimum gross
value to the Company above a certain threshold. All payments under the Letter Agreement (other than base salary) are subject to deduction
of all taxes and other amounts required by law and are subject to the terms of, and subordinate to all amounts due under, the series
of Senior Secured Debentures issued by the Company as of April 29, 2026.
Szoke
Letter
The
Szoke Letter amends Mr. Szoke’s Offer Letter dated as of April 12, 2023 and provides that, effective upon his appointment: (i)
Mr. Szoke’s responsibilities will comprise managing and overseeing all operations and matters of the Company and its subsidiaries,
together with such other functions as are customarily applicable to his position or as are reasonably assigned to him by the Board; (ii)
Mr. Szoke’s annual base salary will be increased to $300,000; (iii) the Company will pay Mr. Szoke a cash bonus of $10,000 within
five business days; and (iv) the Company will pay Mr. Szoke a cash bonus of $210,000 within five business days following the closing
of a Corporate Transaction, provided that he continues to serve as Chief Executive Officer on the date of such closing.
Daguro
Letter.
The
Daguro Letter amends the Retention Agreement, including Sections 4.1 through 4.4 thereof, and replaces in their entirety the letters
from the Compensation Committee of the Board to Mr. Daguro dated as of February 20, 2026 and May 26, 2026, which are of no further force
or effect. The Daguro Letter provides, among other things, that:
| ● | the
Company will provide Mr. Daguro a monthly special stipend at the existing level of the premiums
necessary to fund ongoing health care coverage for Mr. Daguro and his dependents under the
Company’s health care plan for up to 12 months from his termination date, or if earlier,
until he secures other coverage; |
| ● | the
Company will pay Mr. Daguro a cash bonus of $400,000 within five business days following
the closing of a Corporate Transaction, provided that he has not resigned as Chairman of
the Board prior to such closing; |
| ● | with
respect to all stock options previously granted to Mr. Daguro, (A) the vesting of all unvested
stock options will continue for so long as he holds office as a director of the Company,
and (B) the exercisability of such options is extended to the date that is three years following
his cessation of service as a director of the Company; |
| ● | the
Company will grant Mr. Daguro (A) options to purchase 80,000 shares of common stock at an
exercise price equal to two times the Nasdaq Official Closing Price on August 28, 2026, subject
to such exercise price being not less than the Nasdaq Official Closing Price on the date
of grant, and (B) a warrant to purchase up to 20,000 shares of common stock at an exercise
price of $2.00 per share, with a two year time period, upon payment by Daguro to the Company
of $10,000 in cash or cash equivalents within six months of the date of the Daguro Letter.
These grants will be made once the trading window for the Company’s stock opens in
accordance with the Company’s Insider Trading Policy; |
| |
● |
Mr. Daguro
will be eligible for, and will receive, the benefits and compensation the Company provides to its non-employee directors for so long
as he serves as a director; and |
| |
|
|
| |
● |
the payments
due under Section 4.1 of the Retention Agreement will be due and payable (A) on a pro-rated monthly basis until such time as Mr.
Daguro secures alternative employment at a base salary of not less than $400,000 per annum, and (B) with the first payment, which
will include all amounts accrued from the date of Mr. Daguro’s August 26, 2026 letter, due as stated in the Retention Agreement
but paid within five business days following the closing of a Corporate Transaction, and thereafter in accordance with the payment
schedule set forth in Section 4.1 of the Retention Agreement. |
Mr.
Daguro has agreed to provide a release of claims as required by Section 7.3 of the Retention Agreement upon the first payment made under
the Daguro Letter, excluding claims arising out of the Daguro Letter and the Retention Agreement as amended, rights of indemnification
thereunder or pursuant to the Company’s By-Laws, Certificate of Incorporation or applicable law, and claims relating to his ownership
of issued or granted equity or securities of the Company.
The
foregoing descriptions of the Szoke Letter and the Daguro Letter do not purport to be complete and are qualified in their entirety by
reference to the full text of the Szoke Letter and the Daguro Letter, copies of which are filed as Exhibit 10.1 and Exhibit 10.2, respectively,
to this Current Report on Form 8-K and are incorporated herein by reference.
Cautionary
Note Regarding Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including statements regarding the Company’s leadership transition and the anticipated effectiveness thereof,
the Company’s pursuit and possible consummation of a Corporate Transaction, and the timing and amount of the payments and equity
awards contemplated by the Letter Agreements. These statements are based on management’s current expectations and are subject to
known and unknown risks and uncertainties, including the Company’s ability to raise additional capital on acceptable terms or at
all, substantial doubt regarding the Company’s ability to continue as a going concern, the risk that the Company does not identify
or consummate a Corporate Transaction, the effects of the leadership transition on the Company’s business, employees, customers
and partners, the Company’s ability to retain key personnel and to identify and appoint a permanent Chief Executive Officer, and
the other factors described under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December
31, 2025 and in its subsequent filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date
on which they are made, and the Company undertakes no obligation to update any forward-looking statement, except as required by law.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
| Exhibit
No. |
|
Description |
| 10.1* |
|
Letter Agreement dated August 28, 2026 between authID Inc. and Thomas R. Szoke. |
| 10.2* |
|
Letter Agreement dated August 28, 2026 between authID Inc. and Rhoniel A. Daguro. |
| 104 |
|
Cover Page Interactive
Data File (embedded within the Inline XBRL document). |
| * | Certain
confidential portions of this exhibit were omitted by means of marking such portions with
asterisks because the identified confidential portions (i) are not material and (ii) is the
type that the registrant treats as private or confidential. A copy of any omitted portions
will be furnished to the SEC upon request. |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
authID
Inc. |
| |
|
|
| Date: September 1, 2026 |
By: |
/s/
Edward Sellitto |
| |
Name: |
Edward Sellitto |
| |
Title: |
Chief Financial Officer |